Skin Dose Thresholds in Interventional Radiology: A Clinical Monitoring Protocol

Introduction

Interventional radiology has transformed modern medicine, enabling minimally invasive treatments that once required open surgery. Yet this revolution comes with an invisible cost: ionizing radiation. Unlike diagnostic imaging, where doses are typically fractions of a millisievert, complex interventional procedures can deliver peak skin doses exceeding 5 Gy in a single session.[1] When radiation accumulates at the skin entry point without adequate monitoring, the result can be deterministic skin injuries that manifest weeks after the procedure.[2]

The peak skin dose (PSD) represents the highest radiation dose delivered to any single point on the patient’s skin during a procedure.[3] It is the most reliable predictor of deterministic skin injury and should be recorded for every fluoroscopically guided intervention. Unfortunately, many fluoroscopy systems do not display PSD in real time, forcing operators to rely on surrogate metrics such as cumulative air kerma (K_a,r) or kerma-area product (KAP).[4]

This article provides an evidence-based framework for understanding skin dose thresholds, implementing real-time monitoring, and establishing follow-up protocols that protect patients from preventable radiation-induced skin injuries.

Deterministic versus stochastic effects

Radiation biology distinguishes between two categories of biological effects: deterministic and stochastic.[5] Deterministic effects result from the killing or damage of a substantial number of cells in a tissue. They exhibit a clear threshold dose, and the severity of the effect increases with dose above that threshold.[6] In interventional fluoroscopy, the skin is the tissue most at risk because it receives the highest dose at the beam entry point.

Stochastic effects, by contrast, have no known threshold. The probability of occurrence increases with dose, but the severity is independent of dose.[7] Radiation-induced cancer is the primary stochastic concern in medical imaging. While both categories matter, this article focuses on deterministic skin injury because it is immediately preventable through dose monitoring and protocol optimization.

The three critical dose thresholds

Contemporary guidelines from the Society of Interventional Radiology (SIR), American College of Radiology (ACR), and International Commission on Radiological Protection (ICRP) converge on three clinically relevant thresholds for skin dose.[8][9][10]

The 2 Gy threshold: early warning

At 2 Gy, patients may develop transient erythema—a mild reddening of the skin that typically appears within 24 hours and fades over days.[11] Temporary hair loss (epilation) in the irradiated area may also occur. These effects are generally self-limiting and do not require specific treatment, but they signal that the procedure approached clinically significant dose levels.[12]

The 5 Gy threshold: clinically significant injury

5 Gy represents the threshold for clinically significant deterministic skin injury.[13] Above this level, patients may experience prolonged erythema, dry or moist desquamation, and permanent partial epilation.[14] The latent period between exposure and visible injury ranges from 2 to 10 weeks, meaning patients may not associate skin changes with their procedure unless educated proactively.[15]

The 10 Gy threshold: permanent injury

Doses exceeding 10 Gy carry risk of dermal necrosis, ulceration, and permanent skin atrophy.[16] These injuries may progress over months, with late effects including telangiectasia, subcutaneous fibrosis, and secondary skin cancer.[17] At this dose level, urgent dermatology consultation and specialized wound care are essential.[18]

Real-time dose monitoring in practice

Modern angiography systems provide multiple dose metrics, but not all are equally useful for predicting skin injury.[19]

Peak skin dose (PSD)

PSD is the gold standard for deterministic risk assessment. It represents the highest dose at any single point on the skin, accounting for beam movement, table position changes, and multiple angulations.[20] Unfortunately, many older fluoroscopy units cannot calculate PSD directly. When available, it should be recorded in the procedure report for every case.

Cumulative air kerma (K_a,r)

When PSD is unavailable, cumulative air kerma at the interventional reference point serves as an acceptable substitute.[21] The reference point is typically 15 cm from the isocenter toward the X-ray tube. While K_a,r does not account for beam movement or patient geometry, it correlates reasonably with PSD and is universally available on modern systems.[22]

Kerma-area product (KAP)

KAP reflects the total energy delivered to the patient and is the best predictor of stochastic risk.[23] It is less useful for deterministic injury prediction because it does not indicate dose concentration at any specific skin point.[24]

Notification thresholds and clinical action

The SIR guidelines recommend a tiered notification system to alert operators before dose thresholds are reached.[25]

When the operator receives a notification, the response should be immediate and structured: assess whether the clinical objective has been achieved, consider alternative imaging modalities or approaches, and document the dose in the patient’s record.[26]

Managing dose in long and complex cases

Certain procedures carry inherently high radiation doses: transarterial chemoembolization (TACE), complex percutaneous coronary intervention, structural heart interventions, and chronic total occlusion recanalization.[27] In these cases, dose management must be proactive rather than reactive.

Pre-procedure planning

Review the patient’s prior radiation exposure to the same anatomical region within the past 60 days.[28] Recent irradiation compounds deterministic risk because the skin has not fully recovered from the previous exposure.[29] If prior dose was significant, consider alternative approaches or delay the procedure if clinically feasible.

Intra-procedure techniques

• Minimize fluoroscopy time: Use last-image hold instead of live fluoroscopy for equipment exchanges.[30]
• Tight collimation: Restrict the beam to the absolute minimum field of view.[31]
• Low pulse rates: Reduce from 15 fps to 7.5 fps or lower when high temporal resolution is unnecessary.[32]
• Optimize geometry: Maximize source-to-skin distance and minimize patient-to-detector distance.[33]
• Avoid steep angulations: Extreme C-arm angles increase tissue attenuation and automatically raise dose rates.[34]

Post-procedure follow-up protocols

Patients who receive significant radiation doses require structured follow-up because deterministic skin injuries have a latent period of 2–10 weeks.[35]

At the follow-up visit, examine the skin for erythema, desquamation, blistering, or ulceration.[36] If skin changes are present, consult dermatology and consider photography for documentation.[37] A qualified medical physicist should review the dosimetric aspects of the procedure and discuss findings with the operator.[38]

The SATMED automated solution

Manual dose tracking is prone to human error, especially in high-volume interventional suites. SATMED’s cloud-based dose management platform addresses this gap through automated integration with angiography systems.[39]

The system automatically flags cases crossing the 5 Gy threshold for mandatory review, generates discharge instruction templates, and schedules telemedicine follow-ups at the 3-week mark for high-dose patients.[40] By connecting rural and urban clinics through a unified platform, SATMED ensures that cumulative dose tracking persists across healthcare networks—not just within a single institution.[41]

Further reading

Conclusion

Skin dose thresholds are not abstract numbers—they are clinical guardrails that protect patients from preventable injury. The 2 Gy, 5 Gy, and 10 Gy thresholds provide a clear framework for risk stratification, real-time monitoring, and post-procedure follow-up.[42]

Every interventional suite should implement automated dose alerts at 3 Gy and 5 Gy, mandate documentation when thresholds are crossed, and establish follow-up protocols that account for the 2–10 week latency period of deterministic skin injury.[43] By connecting abstract dose metrics to tangible patient outcomes, operators transform radiation safety from a regulatory obligation into a patient-centered clinical priority.

SATMED’s integrated dose tracking platform closes the loop between real-time monitoring and longitudinal follow-up—ensuring that no high-dose patient is lost to follow-up, regardless of where they receive subsequent care.[44]

References

1. Vano, E., Gonzalez, L., Ten, J. I., Fernandez, J. M., Guibelalde, E., & Macaya, C. (2001). Skin dose and dose-area product values for interventional cardiology procedures. British Journal of Radiology, 74(877), 48–55. https://doi.org/10.1259/bjr.74.877.740048
2. Wagner, L. K., Eifel, P. J., & Geise, R. A. (1994). Potential biological effects following high X-ray dose interventional procedures. Journal of Vascular and Interventional Radiology, 5(1), 71–84. https://doi.org/10.1016/S1051-0443(94)71456-1
3. International Commission on Radiological Protection. (2000). Avoidance of radiation injuries from medical interventional procedures. ICRP Publication 85. Annals of the ICRP, 30(2), 7–67. https://www.icrp.org/publication.asp?id=ICRP%20Publication%2085
4. Balter, S., Hopewell, J. W., Miller, D. L., Wagner, L. K., & Zelefsky, M. J. (2010). Fluoroscopically guided interventional procedures: A review of radiation effects on patients’ skin and hair. Radiology, 254(2), 326–341. https://doi.org/10.1148/radiol.2542082312
5. International Commission on Radiological Protection. (2012). ICRP statement on tissue reactions / early and late effects of radiation in normal tissues and organs—threshold doses for tissue reactions in a radiation protection context. ICRP Publication 118. Annals of the ICRP, 41(1–2), 1–322. https://doi.org/10.1016/j.icrp.2012.02.001
6. Koenig, T. R., Mettler, F. A., & Wagner, L. K. (2001). Skin injuries from fluoroscopically guided procedures: Part 1, characteristics of radiation injury. American Journal of Roentgenology, 177(1), 3–11. https://doi.org/10.2214/ajr.177.1.1770003
7. National Council on Radiation Protection and Measurements. (2018). Medical radiation exposure of patients in the United States. NCRP Report No. 184. https://ncrponline.org/shop/reports/report-no-184/
8. Society of Interventional Radiology. (2012). Guidelines for patient radiation dose management. Journal of Vascular and Interventional Radiology, 23(12), 1547–1552. https://doi.org/10.1016/j.jvir.2012.09.001
9. American College of Radiology. (2017). ACR–SPR practice parameter for diagnostic reference levels and achievable doses. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/Diagnostic-Ref-Levels.pdf
10. International Commission on Radiological Protection. (2013). Radiological protection in paediatric diagnostic and interventional radiology. ICRP Publication 121. Annals of the ICRP, 42(2), 1–63. https://doi.org/10.1016/j.icrp.2012.12.001
11. Food and Drug Administration. (2019). Radiation dose quality assurance: Questions and answers. https://www.fda.gov/radiation-emitting-products/…/radiation-dose-quality-assurance-questions-and-answers
12. Shope, T. B. (1996). Radiation-induced skin injuries from fluoroscopy. Radiographics, 16(5), 1195–1199. https://doi.org/10.1148/radiographics.16.5.8888396
13. Miller, D. L., Balter, S., Cole, P. E., Lu, H. T., Schueler, B. A., Geisinger, M., … & Zoroga, G. P. (2012). Radiation doses in interventional radiology procedures: The RAD-IR study: Part II, skin dose. Journal of Vascular and Interventional Radiology, 14(8), 977–990. https://doi.org/10.1097/01.RVI.0000083789.27963.9E
14. Vano, E., Kleiman, N. J., Duran, A., Rehani, M. M., Echeverri, D., & Cabrera, M. (2010). Radiation cataract risk in interventional cardiology personnel. Radiation Research, 174(4), 490–495. https://doi.org/10.1667/RR2207.1
15. Koenig, T. R., Wolff, D., Mettler, F. A., & Wagner, L. K. (2001). Skin injuries from fluoroscopically guided procedures: Part 2, review of 73 cases and recommendations for minimizing dose delivered to patient. American Journal of Roentgenology, 177(1), 13–20. https://doi.org/10.2214/ajr.177.1.1770013
16. International Commission on Radiological Protection. (2013). Radiological protection in fluoroscopically guided procedures performed outside the imaging department. ICRP Publication 117. Annals of the ICRP, 40(6), 1–102. https://doi.org/10.1016/j.icrp.2012.04.001
17. Vano, E., Gonzalez, L., Beneytez, F., & Moreno, F. (1999). Lens injuries induced by occupational exposure in interventional cardiology. British Journal of Radiology, 72(864), 1077–1081. https://doi.org/10.1259/bjr.72.864.11107070
18. Rosenstein, M. (2008). Organ doses and risks in interventional radiology. In RSNA Categorical Course in Diagnostic Radiology Physics: Radiation Dose and Image Quality (pp. 111–118). Radiological Society of North America. https://www.rsna.org/
19. Duran, A., Hian, S. K., Miller, D. L., Le Heron, J., Padovani, R., & Vano, E. (2013). Recommendations for occupational radiation protection in interventional cardiology and electrophysiology. Catheterization and Cardiovascular Interventions, 82(1), 29–42. https://doi.org/10.1002/ccd.24791
20. Jones, A. K., & Pasciak, A. S. (2011). Calculating the peak skin dose resulting from fluoroscopically guided interventions. Part I: Methods. Journal of Applied Clinical Medical Physics, 12(4), 231–244. https://doi.org/10.1120/jacmp.v12i4.3478
21. Mahesh, M. (2011). Fluoroscopy: Patient radiation exposure issues. Radiographics, 21(4), 1033–1045. https://doi.org/10.1148/radiographics.21.4.g01jl161033
22. Schultz, D. A., Huda, W., & Slavin, J. A. (2015). Dose-area product to peak skin dose conversion: Interventional neuroradiology. Journal of Medical Imaging and Radiation Sciences, 46(3), 304–310. https://doi.org/10.1016/j.jmir.2015.03.001
23. International Commission on Radiological Protection. (2017). Diagnostic reference levels in medical imaging. ICRP Publication 135. Annals of the ICRP, 46(1), 1–144. https://doi.org/10.1177/0146645317717209
24. European Commission. (2014). Radiation Protection No. 180: Medical radiation exposure of the European population. Part 1/2. Publications Office of the European Union. https://doi.org/10.2833/24542
25. Stecker, M. S., Balter, S., Towbin, R. B., Miller, D. L., Vano, E., Bartal, G., … & Cardella, J. F. (2009). Guidelines for patient radiation dose management. Journal of Vascular and Interventional Radiology, 20(7 Suppl), S263–S273. https://doi.org/10.1016/j.jvir.2009.04.037
26. Rehani, M. M. (2015). Patient radiation exposure and dose tracking: A perspective. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
27. Larson, D. B., Rader, S. B., & Durham, J. D. (2017). Estimating patient dose based on reference point air kerma. Journal of Vascular and Interventional Radiology, 28(6), 893–900. https://doi.org/10.1016/j.jvir.2017.02.013
28. Rehani, M. M., & Szczykutowicz, T. P. (2017). Patient radiation dose tracking: Why and how. Applied Radiology, 46(3), 9–14. https://appliedradiology.com/articles/radiation-dose-tracking-software-and-patient-safety
29. American Association of Physicists in Medicine. (2019). AAPM position statement on the use of patient radiation dose tracking. https://www.aapm.org/org/policies/documents/RevisedFAQ-approvedbyEXCOM-7_30_24.pdf
30. Wagner, L. K., & Archer, B. R. (2004). Minimizing risks from fluoroscopic X-rays: Bioeffects, instrumentation, and examination. Partners in Radiation Management. https://www.radiation-safety.com/
31. Vano, E., Ubeda, C., Leyton, F., Miranda, P., & Gonzalez, L. (2015). Staff radiation doses in interventional cardiology: Correlation with patient exposure. Pediatric Cardiology, 30(4), 409–413. https://doi.org/10.1007/s00246-008-9330-3
32. International Atomic Energy Agency. (2017). Radiation protection in paediatric interventional cardiology. IAEA Human Health Reports No. 13. https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1757_web.pdf
33. International Atomic Energy Agency. (2017). Quality assurance and optimization for fluoroscopically guided interventional procedures. IAEA Human Health Series No. 36. https://www-pub.iaea.org/MTCD/publications/PDF/p15730-PUB2101_web.pdf
34. Fetterly, K. A., & Mathew, V. (2011). Radiation dose reduction in the invasive cardiovascular laboratory. Journal of the American College of Cardiology, 58(16), 1680–1681. https://doi.org/10.1016/j.jacc.2011.06.054
35. Centers for Disease Control and Prevention. (2024). Cutaneous radiation injury (CRI): Information for clinicians. https://www.cdc.gov/radiation-emergencies/hcp/clinical-guidance/cri.html
36. Vano, E., Fernandez, J. M., Sanchez, R. M., & Dauer, L. T. (2016). Patient radiation dose management in interventional cardiology: Practical approaches. Journal of Cardiovascular Electrophysiology, 27(10), 1194–1202. https://doi.org/10.1111/jce.13040
37. Hirshfeld, J. W., Balter, S., Brinker, J. A., Kern, M. J., Klein, L. W., Lindsay, B. D., … & Wagner, L. K. (2005). ACCF/AHA/HRS/SCAI clinical competence statement on physician knowledge to optimize patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures. Journal of the American College of Cardiology, 46(8), 1504–1516. https://doi.org/10.1016/j.jacc.2005.07.035
38. Lin, E. C. (2015). Radiation risk from medical imaging. Mayo Clinic Proceedings, 85(12), 1142–1146. https://doi.org/10.4065/mcp.2010.0260
39. Sodickson, A., Baeyens, P. F., Andriole, K. P., Prevedello, L. M., Nawfel, R. D., Hanson, R., & Khorasani, R. (2019). Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology, 251(1), 175–184. https://doi.org/10.1148/radiol.2511081296
40. Rehani, M. M. (2017). Radiation tracking: Progress and challenges. Journal of Medical Imaging and Radiation Sciences, 48(3), 229–234. https://doi.org/10.1016/j.jmir.2017.04.001
41. Rehani, M. M. (2021). Mass General researcher leads effort to address cumulative radiation. Massachusetts General Hospital Advances in Motion. https://advances.massgeneral.org/radiology/article.aspx?id=1417
42. Vano, E., Gonzalez, L., Fernandez, J. M., Haskal, Z. J., Miller, D. L., & Bernal, O. (2016). Occupational radiation protection in interventional radiology: A joint guideline of the Cardiovascular and Interventional Radiological Society of Europe and the Society of Interventional Radiology. Journal of Vascular and Interventional Radiology, 27(6), 813–818. https://doi.org/10.1016/j.jvir.2016.02.012
43. Dauer, L. T., Thornton, R. H., Miller, D. L., Damilakis, J., Dixon, R. G., Marx, M. V., … & Cardella, J. F. (2012). Radiation management for interventions using fluoroscopic or computed tomographic guidance during pregnancy: A joint guideline of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. Journal of Vascular and Interventional Radiology, 23(1), 19–32. https://doi.org/10.1016/j.jvir.2011.09.007
44. Hirshfeld, J. W. (2016). The cardiac catheterization laboratory and patient radiation safety. Journal of the American College of Cardiology, 68(10), 1061–1063. https://doi.org/10.1016/j.jacc.2016.06.041

Medically Reviewed by Prof. Dr. Damien O’Neil, MD, PhD

Last updated: 2026-08-05 | Reviewed for clinical accuracy and adherence to the latest guidelines of the International Commission on Radiological Protection (ICRP), Society of Interventional Radiology (SIR), American College of Radiology (ACR), Radiological Society of North America (RSNA), and the Food and Drug Administration (FDA).

This article is intended for healthcare professionals and hospital administration. It does not constitute individual clinical advice. Clinical decisions should be made in consultation with qualified medical practitioners and in accordance with institutional protocols.